News About: Pharm. Industry
Prices of cold remedies to rise 20%
The prices of Dong-A's Panpyrin-F and Dongwha's Pancol-A, local popular brands for common cold, are expected to rise by 20 percent next January.
The two companies said on December 4 they plan to raise the prices o...
Prices of 1,397 items to be readjusted from next February
A total of 1,397 drugs covered by national health insurance, including LG Life Sciences's Zanidip (lercarnidipine), will be subject to price readjustment from January 1, next year, the Ministry of Health and Welfare s...
10 Korean companies to join anti-alopecia market
Finasteride-based anti-alopecia preparations will be newly spotlighted in the domestic market, as more than ten generic makers homegrown medicines for hair loss are lining up side by side with MSD Korea's Propecia.
...
Markets for no smoking aids showing big changes.
The no-smoking aid markets shed a restructuring sign amid many market recontracts and other co-marketing activities, which all happened at the same time.
According to a reliable drug distribution circle on Nov. 30,...
Green Cross to develop a cell therapy with Samsung and SNU hospitals.
In association with Seoul Samsung hospital and SNU hospital Green Cross is trying to develop a next generation of cell therapy.
The cell therapy has been developed mainly by an individual clinician or venture compa...
Pfizer Korea to sell its consumer healthcare business to Johnson & Johnson Korea
Pfizer Korea plans to sell its Consumer Healthcare (PCH) business to Johnson & Johnson Korea in the middle of this month following Pfizer Inc's decision to drive long-term growth in priority areas such as Alzheimer's ...
Zydena is under approval process in China
Dong-A PharmTech Co., Ltd. is an affiliate of Dong-A Pharmaceutical Co. Ltd., said it initiated the approval process for Zydena, its new erectile dysfunction drug, in China by filing for import verification.
The co...
Stilnox CR now available in Korea
Sanofi-aventis Korea announced on December 1 that Stilnox CR (zolpidem tartrate extended-release tablets), a new extended-release formulation of the best-selling prescription sleep aid Stilnox, is now available by pre...
Hanmi wins $50 million export tower
Hanmi Pharm won its $50 million tower in a ceremony marking the 43rd Trade Day at the Convention Exhibition Center in Seoul on December 1.
This is the first drug export records by pharmaceutical bulk materials and ...
Joint research center founded at a world level of gene therapy.
A joint research and development center will be founded by a Korean government supported research institute and an outstanding American bio venture company for a successful development of new gene therapy, cell therap...
